A high level of carotenes in the blood is linked with a lower degree of atherosclerosis in the arteries and thus a lower risk of cardiovascular diseases.
FDA approves Ionis’ TRYNGOLZA for FCS treatment
Ionis has confirmed that the therapy will be available in the US before the end of 2024. Credit: Ionis Pharmaceuticals, Inc. The US Food and